|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: Anti-Infective Peptides
La Merie, Jan 2009, Pages: 41
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective peptides as of January 2009. Stages of the anti-infective peptide R&D projects range from early research to market.
Anti-Viral Peptides:
Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV).
Anti-Bacterial Peptides:
Anti-bacterial peptides are used to treat infectious diseases such as complicated skin and skin structure infections (cSSSI), gram+ and gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more.
Anti-Fungal Peptides:
Anti-fungal peptides are used to treat infections such as oesophageal candidiasis, aspergillosis, oral candida infections, vaginal yeast infections and many more
Customers who bought this item also bought
Competitor Analysis: PTH Receptor Agonists
Infections Fungal Infections or Candidiasis
Infections Bacterial Infections
The 2009-2014 World Outlook for Anti-Infective Pharmaceutical Preparations Affecting Anthelminics
The 2009-2014 Outlook for Anti-Infective Pharmaceutical Preparations Affecting Anthelminics in Japan
Bacterial Infections: An Epidemiological Overview
Bacterial Infections: An Epidemiological Overview
Infections - Fungal Infections or Candidiasis Drug Pipeline Report
The Anti-Infectives Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities
Stakeholder Opinions: Nosocomial Infections - The Need for New Gram-negative Drugs
The Global Anti-Infectives Market Outlook to 2011
The 2009-2014 World Outlook for Anti-Infective Pharmaceutical Preparations Affecting Amebacides and Trichomonicides
|
|
|
|
